TickerFacts.

Myriad Genetics Inc (MYGN): Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2017-06-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$824.50M
Year ended 2025-12-31
$806.60M
Trailing 12 months to 2026-06-30
+6.7%
3-year compound annual growth
+8.2%
5-year compound annual growth
$851.10M2015-06-30: $722.50M2016-06-30: $740.50M2017-06-30: $728.70M2018-06-30: $743.70M2019-06-30: $851.10M2020-12-31: $557.10M2021-12-31: $690.60M2022-12-31: $678.40M2023-12-31: $753.20M2024-12-31: $837.60M2025-12-31: $824.50M$824.50M
2015-06-30 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$824.50M-1.6%2026-02-24, From 2025-01-01
2024-12-31$837.60M+11.2%2026-02-24, From 2024-01-01
2023-12-31$753.20M+11.0%2026-02-24, From 2023-01-01
2022-12-31$678.40M-1.8%2025-02-28, From 2022-01-01
2021-12-31$690.60M+24.0%2024-02-28, From 2021-01-01
2020-12-31$557.10Mn/a2022-02-25, From 2020-01-01
No annual figure between 2019-06-30 and 2020-12-31.
2019-06-30$851.10M+14.4%2022-02-25, From 2018-07-01
2018-06-30$743.70M+2.1%2020-08-13, From 2017-07-01
2017-06-30$728.70Mn/c2019-08-13, From 2016-07-01
2016-06-30$740.50M+2.5%2018-08-24, From 2015-07-01
2015-06-30$722.50Mn/a2018-08-24, From 2014-07-01

Revenue at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Myriad Genetics Inc (MYGN)2025-12-31$824.50M-1.6%
Neogen Corp (NEOG)2026-05-31$870.40M-2.7%
Lantheus Holdings, Inc. (LNTH)2025-12-31$1.54B+0.5%
QuidelOrtho Corp (QDEL)2025-12-28$2.73B-1.9%
Idexx Laboratories Inc (IDXX)2025-12-31$4.30B+10.4%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$67.67M+16.9%
Alpha Teknova, Inc. (TKNO)2025-12-31$40.52M+7.4%
Immucell Corp (ICCC)2025-12-31$27.64M+4.3%
Aspira Women's Health Inc. (AWHL)2025-12-31$9.22M+0.4%

Compare MYGN, NEOG, LNTH, QDEL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗